ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Merus NV

Merus NV (2GH)

42.20
0.80
(1.93%)
Closed December 08 4:00PM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
42.20
Bid
41.80
Ask
42.80
Volume
0.00
0.00 Day's Range 0.00
21.40 52 Week Range 58.50
Previous Close
41.40
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
127
Financial Volume
-
VWAP
-

2GH Latest News

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC Studie mit Petosemtamab in Kombination mit Pembrolizumab bei 1L...

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m...

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1-2.3148148148143.2474319244.19451697DE
4-7.8-15.65051.540.411744.74603537DE
12-3-6.6371681415945.251.540.412747.17167127DE
26-6-12.448132780148.257.540.415948.57608533DE
5219.283.47826086962358.521.39999917344.34418355DE
15618.477.310924369723.858.51916742.00023485DE
26018.477.310924369723.858.51916742.00023485DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TE9Teco 2030 ASA
0.0592 €
(65.36%)
2.11M
A6NAsana Inc
21.00 €
(43.84%)
19.08k
NL8Genesis Ai Corp
0.0214 €
(40.79%)
13.33k
RQ0DWave Quantum Inc
4.814 €
(34.92%)
1.15M
K8DWellfield Technologies Inc
0.0342 €
(34.65%)
30.8k
AXIAtos SE
0.0028 €
(-98.58%)
1.59B
M0YNMynaric AG
1.40 €
(-72.66%)
303.13k
W47Grid Battery Metals Inc
0.0115 €
(-39.47%)
7
47GAGo Metals Corp
0.0202 €
(-36.88%)
3.44k
4APApollo Minerals Ltd
0.0055 €
(-35.29%)
270.7k
AXIAtos SE
0.0028 €
(-98.58%)
1.59B
D7GNel ASA
0.2625 €
(-1.69%)
4.24M
LK1Lake Resources
0.029 €
(-6.75%)
2.32M
TUI1Tui AG
8.40 €
(1.11%)
2.17M
TE9Teco 2030 ASA
0.0592 €
(65.36%)
2.11M

Discussion

View Full Feed
Skulls999 Skulls999 5 minutes ago
Maybe someone that's is a lot more knowledgeable can call Pentex.
See if they are in a JV with MVNT- Hi Alloy or any others. Did they actually sign a 10 million dollar contract.
Who was the container built for.
Maybe we can get some answers from Pentex. Just a thought!
MVNT
cojoboy cojoboy 6 minutes ago
I can not help myself...I'm an idiot..you know that..lol..😆😆😆
IGPK
Zorch305 Zorch305 6 minutes ago
You sure there is 40 billion OS rumor is that its alot less but you know rumors lets see updated share count
RNVA
Cologne9672 Cologne9672 7 minutes ago
Not this one. This was buried six feet deep.
CRGP
janice shell janice shell 7 minutes ago
Beats me. Maybe couldn't find the right one?
CRGP
bas2020 bas2020 8 minutes ago
I believe it was from the Big Biz Show. He was projecting an expectation based on Fall approval and IMO the likely partnerships that will be concurrently announced.
NWBO
Cologne9672 Cologne9672 9 minutes ago
Why didn’t the other guys post the links?
CRGP
Vexari Vexari 9 minutes ago
Not long
how long do you think it will take to sort out Laws and orders

Are coming to fruition

While the cartel

Is exposed
StayHumble StayHumble 10 minutes ago
UPDATE 💹Funders Wait 💹2Ensure $DBMM Still Trades💹idiot.

$DBMM has the Ability to move forward, to continue to grow its business, benefits its shareholders and asks that the Commission affirm the decision of the Law Judge denying revocation of its registration.
DBMM
JJ8 JJ8 11 minutes ago
Googl share price had a Low Pole Reversal on 2 Dec 2024. GLTA
GOOG
delerious1 delerious1 11 minutes ago
I guess someone missed this part of the summary but...."However, by 1995, falling gold prices caused mining operations to be suspended, and except for limited periods of sporadic activity over the next few years, the mine was put on care and maintenance. ".

...which brings us to the p
NBRI
bas2020 bas2020 12 minutes ago
LOL... You're fooling no one. You own 0 shares. 👿☠️
NWBO
Juststoppingby Juststoppingby 13 minutes ago
Nasdaq Global Select Market: Financial Requirements
Companies (including those listing in connection with a Direct Listing) must meet all of the criteria under at least one
of the four financial standards below and the applicable liquidity requirements on the next page. These
r
CRTG
gp22 gp22 13 minutes ago
$VVOS: Heads Up....$VVOS Patent granted 11/26/24..Yet to issue news release...Link:

Here is a link to the image posted on StockTwits.

Click on link:
https://media.stocktwits-cdn.com/api/3/media/489008
VVOS
gp22 gp22 14 minutes ago
$VVOS: Heads Up....$VVOS Patent granted 11/26/24..Yet to issue news release...Link:

Here is a link to the image posted on StockTwits.

Click on link:
https://media.stocktwits-cdn.com/api/3/media/489008
VVOS
1jas 1jas 15 minutes ago
just trying to make sense of what's going on like some of us are.
KGKG
JOoa0ky JOoa0ky 16 minutes ago
Barron & Co don't actually believe in what they claim... otherwise the lawsuit would've been filed already since it's a slam dunk.
FNMA
StayHumble StayHumble 17 minutes ago
💹$5M BUYBACK💹Dividend💹No r/s💹$HCMC 4-point plan

-A buyback of up to $5M of $HCMC common stock.

-A spinoff of certain HCMC assets into a new publicly traded company

-A stock dividend to $HCMC shareholders of the stock in
HCMC
JJ8 JJ8 18 minutes ago
Amazon share price has been in an Ascending Triple Top Breakout since 4-Dec-2024. GLTA
AMZN
cptbac cptbac 19 minutes ago
LP said look a lot different during the ASM. Need the transcripts to back it up but I am 100% certain.

Les created the great later in the fall debate.
ASM
GoldDog83 GoldDog83 19 minutes ago
Monday should see us well over a $. Smart money is loading for much higher PPS. 

GLTA
WKSP
3331 3331 19 minutes ago
Re: Have you really read those financials?

Yes, I have and agree with the insurance office support staffer's assessment, which follows:

"They've been very close to profitability on several occasions. Anyone who reads the balance sheets can see that...on paper they cou
BIEL
Investor082 Investor082 20 minutes ago
Will you still be looking for excuses after UK approval when stock price retraces the gain after momentary approval spike? Has that been your aim these last 10 odd years and making money on investment, opportunity cost, and accountability is not of concern to you?
NWBO
Sunnybank Sunnybank 20 minutes ago
Then we execute the sell orders fire in the theater
ICTY
gp22 gp22 20 minutes ago
$TSSI: News 12/6/24: Supplies hardware for Hyper Data Centers. Elon via $DELL..Started trading on Nasdaq 11/12/24...Total shares 21M w/40% insider owned...$TSSI considered a core AI position stock by many.. Links

News: Note: $TSSI "Primary customer" is $DELL in support of Elon Musk.
DELL TSSI

Your Recent History

Delayed Upgrade Clock